PMID: 9174208Jun 1, 1997Paper

Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy
N N Baranova, A A Neyfakh

Abstract

A Streptococcus pneumoniae strain selected for resistance to ethidium bromide demonstrated enhanced energy-dependent efflux of this toxic dye. Both the ethidium resistance and the ethidium efflux could be inhibited by the plant alkaloid reserpine. The ethidium-selected cells demonstrated cross-resistance to the fluoroquinolones norfloxacin and ciprofloxacin; this resistance could also be completely reversed by reserpine. Furthermore, reserpine potentiated the susceptibility of wild-type S. pneumoniae to fluoroquinolones and ethidium. The most plausible explanation for these results is that S. pneumoniae, like some other gram-positive bacteria, expresses a reserpine-sensitive multidrug transporter, which may play an important role in both intrinsic and acquired resistances of this pathogen to fluoroquinolone therapy.

References

Aug 1, 1976·Journal of Virology·R D Porter, W R Guild
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A A NeyfakhL B Chen
Nov 3, 1995·The Journal of Biological Chemistry·H BolhuisW N Konings
Jan 1, 1993·Antimicrobial Agents and Chemotherapy·A A NeyfakhG W Kaatz
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·H E TakiffW R Jacobs
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·H W van VeenW N Konings
Oct 1, 1996·Antimicrobial Agents and Chemotherapy·X S PanL M Fisher
Dec 1, 1996·Microbiological Reviews·I T PaulsenR A Skurray
Feb 1, 1997·Journal of Bacteriology·R Ohki, M Murata
Dec 1, 1996·Antimicrobial Agents and Chemotherapy·C JanoirL Gutmann

❮ Previous
Next ❯

Citations

Nov 11, 1999·Medicinal Research Reviews·V J Lee, S J Hecker
Jul 5, 2005·Expert Opinion on Investigational Drugs·L E Lawrence, J F Barrett
Dec 20, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Deborah CorcoranSéamus Fanning
Jan 27, 2006·Antimicrobial Agents and Chemotherapy·Inshad Ali KhanGhulam Nabi Qazi
Nov 2, 2012·Antimicrobial Agents and Chemotherapy·Nadia TocciMarco Rinaldo Oggioni
Dec 6, 2000·Microbiology and Molecular Biology Reviews : MMBR·M PutmanW N Konings
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Laura J V Piddock, M M Johnson
Oct 20, 2001·Pharmacotherapy·D T Bearden, L H Danziger
Jul 4, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M KiB Foxman
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·S RaherisonC M Bébéar
Jan 14, 2004·Drugs·Xian-Zhi Li, Hiroshi Nikaido
Dec 2, 2004·Acta Microbiologica Et Immunologica Hungarica·J MolnárYvette Mándi
Apr 15, 2006·Clinical Microbiology Reviews·Laura J V Piddock
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·C JanoirL Gutmann
Oct 31, 1998·Antimicrobial Agents and Chemotherapy·X S Pan, L M Fisher
May 1, 1999·Antimicrobial Agents and Chemotherapy·T A DaviesP C Appelbaum
Oct 3, 1999·Antimicrobial Agents and Chemotherapy·P N MarkhamA A Neyfakh
Oct 3, 1999·Antimicrobial Agents and Chemotherapy·M J FerrándizA G De La Campa
Jan 30, 1999·Antimicrobial Agents and Chemotherapy·H Fukuda, K Hiramatsu
Aug 4, 1998·Antimicrobial Agents and Chemotherapy·S MiyamaeF Yoshimura
Apr 16, 2021·The Journal of Antimicrobial Chemotherapy·Elisa RampacciFabrizio Passamonti
Aug 16, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·David C. Hooper
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L R Peterson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

© 2021 Meta ULC. All rights reserved